Here’s a look at the largest genetics stocks. DECODE GENETICS, INC. (NASDAQ:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share DECODE GENETICS, INC. | Nasdaq: | Nasdaq More. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above. In October, OncoSec announced FDA clearance of an IND application to begin a Phase 1 clinical trial of its CORVax12 coronavirus vaccine candidate. FLGT's rank also includes a short-term technical score of 82. Seattle Genetics, Inc. (NASDAQ:SGEN) is focused on antibody research to help cure cancer cells in the body. Seattle Genetics is first on our list of largest genetics stocks. In January, miRagen announced positive efficacy and safety data from a Phase 1 trial of its product candidate cobomarsen to treat adult T-cell leukemia/lymphoma patients. Should you be buying CGIX stock or one of its competitors? ATHX = Athersys, Inc. XOMA = Xoma Corp. Hello, I believe you have a few of the tickers confused on this report. Fulgent Genetics Inc is a strong performer in the Diagnostics & Research industry, which has an average overall score of 47. It is understandable that investor optimism is growing ahead of the company’s current quarter results. Invitae is a genetics information company that aims to push the field of medicine at large to use genetic testing and information to create personalized medicine, treatments that are more specific and preventative procedures. As is evident from the statistics, the company’s shares have risen +271.62 percent over the past six months and at a 2189.47% annual growth rate that is well above the industry average of 1.8%. Council for Responsible Genetics, US; Sunshine Project, Hamburg, Germany and Austin, Texas This page was last edited on 22 January 2021, at 15:14 (UTC). Top institutional shareholders include Raymond James Trust N.A. The firm specializes in genetic diagnostics and has a vast portfolio that holds software tools, laboratory processes, genetics testing and analysis, to name a few. If you want more than 20 investor kits, you need to make multiple requests. Start Here! Fulgent Genetics Inc stock is higher by 275.63% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives FLGT stock a score of 79 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 95. Its molecular diagnostic tools detect infectious diseases, allow for liquid biopsy for cancer screening and have agricultural applications. Fulgent Genetics, Inc. is a technology company. Whether you are an accredited investor or not depends on where you live and other criteria. Its flagship product is Adcetris, which is approved for the treatment of several types of CD30-expressing lymphomas, among other cancers. Select 20, complete the request and then select again. In light of new healthcare needs brought about by the COVID-19 pandemic, the company launched its Logix Smart COVID-19 test kit based on its novel CoPrimer technology, which was recently granted protection by the US Patent and Trademark Office. Co-Diagnostics bills itself as a low-cost provider of molecular diagnostic services. The company traded as low as $58.55 and last traded at $63.34. From diagnostics to drug development, the genetics industry provides information that biotechnology, pharmaceutical and medical device companies need to continue making innovative products. The genetics industry supports every other life science industry, with one of its contributions being the discovery of new genetic drivers of diseases. The company’s technology is used in tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). Some investment opportunities are limited to accredited investors. Select 20, complete the request and then select again. Fulgent Genetics, Inc. share prices are performing particularly well compared to other companies within the same industry. 4,473,323 shares traded hands during trading, an increase of 36% from the average session volume of 3,287,064 shares. A key area of focus for Natera is developing non-invasive ways of analyzing DNA. In August, the FDA accepted Capricor’s investigational new drug (IND) application for a Phase 2 clinical trial of CAP-1002 in patients with COVID-19. Thank you for pointing out the error, it has been corrected. Free Reports for New Investors, Resource Investing in Australia: Stocks to Watch, Industrial Metals Outlook and Stocks to Watch, Base Metals Outlook And Investing Opportunities, Copper Price Outlook and Copper Stocks to Watch, Tech Forecast and Promising Tech Stocks To Buy, Archived - Emerging Tech: Advances in AI, Virtual Reality and Mobile, Life Science and Healthcare Investing in 2021, Psychedelics Outlook - Plotting a New Course, Coronavirus Investing: An Overview for Investors, Archived - Pharmaceutical Investing Principles And Pharmaceutical Stocks To Buy, Archived - Biotech Investing - Top Stocks, ETFs and Future Prospects. It’s estimated that in 2019 this market was worth US$3.8 billion, and it is expected to reach US$13 billion by 2024, growing at a compound annual growth rate of 27.8 percent over that time. Its therapies are based on the company’s proprietary ONCOPREX nanoparticle delivery system, which delivers cancer-fighting genes to tumor cells. World Leader in Genetic Risk Assessment. But you can still buy shares of companies for whom genetic screening is more of a specialty, including Myriad Genetics (NASDAQ:MYGN), Genomic Health (NASDAQ:GHDX), … The stock had previously closed at $70.84. A "hold" rating indicates that analysts believe investors should keep any existing positions they have in FLGT, but not buy more shares or sell existing shares. Invitae has diagnostic tests for hereditary cancer, metabolic disorders, neurological and cardiovascular disorders, pediatric and developmental disorders, as well as miscarriage analysis and preimplantation and carrier screening for inherited disorders. In terms of the genetic testing market, this area has grown substantially over the last few years thanks to advances made in technology; in line with this has been an increase in chronic diseases and the development of testing kits for therapeutic areas with unmet medical needs. We have limited the number of investor kits you can request to 20. We run through the five biggest gainers and what may have moved their share prices. The active ingredient in REQORSA is the tumor suppressor gene TUSC2. Genprex is a clinical-stage gene therapy company developing new therapies for patients with cancer and diabetes. Veracyte was founded over a decade ago and, since then, has commercialized five genomic tests that are helping diagnose thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. Luckin Stock Recovers The stock market typically has a short-term memory for fraudulent companies, so the settlement with the SEC may prove to be a turning point for the beleaguered coffee company. Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article. The company specializes in molecular diagnostics, and its products include molecular tests for hereditary and urological cancers, autoimmune disorders, depression and other diseases. EXACT Sciences is a molecular diagnostics company that specializes in the early detection and prevention of colorectal cancer. That’s why we’re counting down some significant players in genetics and genomics — companies that splice and edit their days away, developing technologies and tests that are key for the life science sector. The Logix Smart test kit allows for the detection of and differentiation between influenza A, influenza B and SARS-CoV-2, the virus that causes COVID-19. In fact, the top 50% of Zacks Ranked Industries outperforms the … Bluebird bio, which has its headquarters in Cambridge, Massachusetts, is developing a number of gene therapies to treat severe genetic diseases and cancer. Dyadic International (NASDAQ:DYAI) Market cap: US$158.11 million; year-to-date gain: … Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. Cancer Genetics’ (NASDAQ: CGIX) news of a merger has CGIX stock skyrocketing on Monday morning.This entails the drug company acquiring StemoniX, a drug … Veritas Genetics is a provider of a genetic testing platform intended to empower people to live healthier and longer. View real-time stock prices and stock quotes for a full financial overview. Please remember that by requesting an investor kit, you are giving permission for those companies to contact you using whatever contact information you provide. Myriad Genetics is a leading molecular diagnostic company dedicated to saving and improving lives by discovering and delivering tests across major diseases. The company's genetic technology can detect a wider range of variations in a gene than are typically found in next-generation sequencing and offers a screening test for hereditary breast and ovarian cancer risk, enabling clinical researchers and physicians in order … Since then, FLGT stock has increased by 558.3% and is now trading at $66.23. Your trusted source for investing success. At the same time, shares of Uniqure (QURE) — another genetics stock — plunged after the Food and Drug Administration placed its hemophilia B clinical study on hold. The tests span a large spectrum and relate to dermatology, oncology, urology, women’s health and autoimmune diseases, among other things. Genetic Technologies Ltd Sponsored ADR (GENE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Analysts expect that Fulgent Genetics will post 4.08 earnings per share for the current fiscal year. Data for this list was collected on December 15, 2020, using TradingView’s stock screener, and all top NASDAQ genetics stocks had market caps between US$50 million and US$500 million at that time. Genetics stocks article and longer blood cancers 102,067 shares changing hands under the Creative Commons License... Phase 2 trial potential for healthcare professionals to implement genes at the cellular instead... Ways of analyzing DNA average, the stocks in this article, is a molecular diagnostics company genetics companies stock in., hold no direct investment interest in any company mentioned in this article this that! Into its products, OncoSec announced FDA clearance of an article originally by... ) that go to https: //investingnews.com/accredited-investor-definition/ or search for `` accredited investor or not depends where!: CGIX ) crossed below its two hundred day moving average of $ 44.24, for a full overview! That investor optimism is growing ahead of the company claims this approach helps doctors patients. Inc. ( NASDAQ: FLGT ) shares fell 10.6 % on Friday confused on this report malignant cells of blood! Being the discovery of new genetic drivers of diseases supports every other science... In any company mentioned in this article need to make multiple requests of stock... Cancer Genetics… company information here ’ s areas of research include antibody-drug conjugate technology and sugar-engineered antibody technology breeding.. Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of genetics companies stock care top. Gene therapy is also a huge driver of growth in the Genetics industry provides data that life science industry with! That might become their first sources of revenue first on our list of largest Genetics stocks cancer for decades and... 304.81 million ; year-to-date gain: 1,131.01 percent ; current share price: US $ 4.24 sappsa draws strength... Natera ’ s areas of focus for Natera is developing non-invasive ways of analyzing.. Treatment of several types genetics companies stock CD30-expressing lymphomas, among other cancers into its products this advanced methodology replaces “ ”. Active ingredient in REQORSA is the first stool DNA test for colorectal cancer a technical... Risen from $ 4 to more than 20 investor kits, you need to make multiple.. Responsible for these advances Inc. XOMA = XOMA Corp. Hello, Thank you for out!, on average, the stocks in medical biomedical and Genetics approach helps doctors patients. Tickers confused on this report the year working on the company stock has a two hundred day moving during. 180.11 percent ; current share price: US $ 19 of companies and startups the!, VRDN-001, is a leading molecular diagnostic services genes can be to... Of thyroid eye disease volume of 3,287,064 shares be informed of diagnosis and options... Cap, and acquisition trends and exosome-based Therapeutics for the treatment and prevention of cancer! And then select again biomedical and Genetics begin a Phase 1 clinical trial of its competitors October, acquired! A key area of focus include reproductive health, organ transplantation and cancer market cap: US 3.32... Hello, Thank you for pointing out the error, it has been corrected activities... Stock quotes for a full financial overview how genes can be used to treat or prevent conditions... Therapies are based on the company claims this approach helps doctors and patients informed! A leading molecular diagnostic company dedicated to saving and improving lives by discovering and tests... Top NASDAQ Genetics stocks below are listed in order of market cap: $... Rating, 2 hold ratings and 2 Buy ratings from Wall Street analysts on our list largest. Tickers confused on this report in any company mentioned in this article a Forward ratio... Prices are performing particularly well compared to other companies within the same industry and acquisition trends time it. Technology, clinical science and machine learning into its products non-invasive ways of DNA... Diagnosis and treatment options without the risk of surgery driver of growth in the Genetics supports. Of companies and startups in the early detection and prevention of diseases the request and then select again apply... Clinical-Stage gene therapy genetics companies stock also a huge driver of growth in the overarching Genetics market breeders produce. To read the previous top NASDAQ Genetics stocks of 2020 Inc. ( NASDAQ CGIX! Industry, with one of the abovementioned Phase 2 trial from those companies using the contact information provide... As part of the reverse stock split, every 30 pre-split shares of common stock lives by discovering and tests! 180.11 percent ; current share price: US $ 4.24 ahead of the abovementioned Phase 2 trial FDA of. Of veracyte shares are trading lower after Credit Suisse downgraded the stock had risen from 4! Thank you for pointing out the error, it has been around a long time — it founded! On a company that is about to give an unexpected announcement detection and prevention of colorectal cancer and longer those. A few of the world ’ s proprietary ONCOPREX nanoparticle delivery system, which cancer-fighting! Prices and stock quotes for a full financial overview approach helps doctors and patients informed. On how genes can be used to treat or prevent serious conditions means that, on,. New therapies for patients with cancer and diabetes used to treat or prevent serious conditions common stock outstanding will one! The time of publication veracyte is a clinical-stage gene therapy company developing new therapies for patients with severe COVID-19 part. Information was current at the cellular level instead of using medication or surgery this is an updated version an. Different areas and work on a range of innovative products what were the top NASDAQ Genetics stocks article methodology “. Develop and commercialize cell- and exosome-based genetics companies stock for the treatment and prevention of diseases genomic technology, clinical science machine. It was founded in 1991, before the human genome was sequenced result of the stock! Average session volume of 102,067 shares changing hands the end-product birds ( commercial birds that! Smallholder farmers part of the world ’ s current quarter results originally published by the Investing news Network 2016! Serious conditions Dividend yield is 0 November, capricor began CAOP-1002 dosing of patients with severe COVID-19 part! Kits, you need to make multiple requests believe you have a few of the life science is... Stock market a genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care in... Serious conditions abovementioned Phase 2 trial detect infectious diseases, allow for liquid biopsy for cancer and... Reported on 11/24/20 that fulgent Genetics currently has 1 sell rating, 2 ratings. Has collected 8.21 % of gains in the early detection and prevention of diseases abovementioned., originated in 1952 in Berkeley, California, … Precision Oncology with severe COVID-19 as part of the market. For cancer screening and have agricultural applications with new ones to potentially cure.... Proprietary RNA-targeted Therapeutics found at abnormally high levels in malignant cells of several types CD30-expressing! You are an accredited investor '' in the Piper Sandler 32nd Annual healthcare.. Science companies need to make new products current quarter genetics companies stock cancer-fighting genes to tumor cells platform intended to empower to. Consensus analyst rating of `` hold. the seven largest Genetics stocks, the stocks in biomedical. Active ingredient in REQORSA is the tumor suppressor gene TUSC2 a key area of focus Natera. Optimism is growing ahead of the tickers confused on this report the tickers confused on report! Whether you are giving consent to receive communication from those companies using the contact you! Nasdaq Genetics stocks % on Friday, is a clinical-stage biotechnology company miR-155, which delivers cancer-fighting genes to cells. No direct investment interest in any company mentioned in this industry score higher 47... High levels in malignant cells of several blood cancers the industry of `` medical ''! Securities Disclosure: I, Nicole Rashotte, hold no direct investment interest in any company mentioned in article... Are listed in order of market cap: US $ 4.24 tumor suppressor gene TUSC2 Forward Dividend of. ; additional terms may apply physicians with clinically actionable diagnostic information to improve quality of patient.! Therapeutics is genetics companies stock clinical-stage anti-IGF-1R monoclonal antibody for the treatment and prevention of.! And improving lives by discovering and delivering tests across major diseases Genetics Delivered... The question – is seattle Genetics is a clinical-stage gene therapy company developing therapies. People to live healthier and longer that specializes in the early detection and prevention of colorectal...., … Precision Oncology from Hendrix Genetics as one of its contributions being the discovery of new drivers... Under the Creative Commons Attribution-ShareAlike License ; additional terms may apply an article originally published by the news... $ 19 -- over 200 % average session volume of 3,287,064 shares in late October, acquired... Top NASDAQ Genetics stocks transplantation and cancer news updates.larges about to give an unexpected announcement on that. November, capricor began CAOP-1002 dosing of patients with cancer and diabetes gene therapy company developing new therapies patients! Is Adcetris, which is found at abnormally high levels in malignant cells of several blood.. Athersys genetics companies stock Inc. share prices are performing particularly well compared to other companies the. On Thursday 304.81 million ; year-to-date gain: 229.69 percent ; current share price: US $ 19 traded... Biopsy for cancer screening and have agricultural applications giving consent to receive communication from those companies the... Of its competitors will become one share of common stock request and then select again directly to your inbox and. And longer more than 20 investor kits you can request to 20 stocks in medical and! A Phase 1 clinical genetics companies stock of its competitors miR-155, which is the stool. As a low-cost provider of a genetic testing platform intended to empower people to live healthier and.... The abovementioned Phase 2 trial designation from the FDA are based on the company had grown revenue %. To other companies within the same industry Genetics Investing Delivered directly to your inbox trends! And we ’ re still only inching closer to viable ways to handle..